WallStSmart
ATHE

Alterity Therapeutics Ltd

NASDAQ: ATHE · HEALTHCARE · BIOTECHNOLOGY

$4.83
-2.52% today

Updated 2026-06-01

Market cap
$88.31M
P/E ratio
P/S ratio
13.31x
EPS (TTM)
$-0.60
Dividend yield
52W range
$3 – $7
Volume
0.0M

Alterity Therapeutics Ltd (ATHE) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-11.66M$-9.20M$-9.41M$-6.99M$-4.71M$-4.56M$-6.85M$-7.95M$-13.79M$-10.87M$-7.42M$-5.87M$-6.25M$-13.95M$-9.43M$-17.33M$-12.34M$-20.04M$-12.61M$-11.45M
Capital expenditures$55659.00$4558.00$46706.00$36192.00$22667.00$13691.00$26763.00$22000.00$23047.00$28757.00$2307.00$27918.00$62405.00$7022.00$16744.00$10472.00$89147.00$7311.00$5722.00$0.00
Depreciation
Stock-based comp$318168.00$893477.00$1.27M$468835.00$-16500.00$24460.00$764539.00$89138.00$-12016.00$1.88M$1.51M$966571.00$881950.00$979920.00
Free cash flow$-11.71M$-9.20M$-9.46M$-7.03M$-4.73M$-4.57M$-6.87M$-7.97M$-13.81M$-10.90M$-7.42M$-5.89M$-6.31M$-13.96M$-9.45M$-17.34M$-12.43M$-20.04M$-12.61M$-11.45M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00